Biobot Analytics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 33

Biobot Analytics General Information

Description

Developer of a wastewater analysis tool designed to deliver untapped insights into human health and behavior. The company's tool generates public health data that is naturally anonymized to yield insights into health and sells data as a service, building and monetizing proprietary datasets and providing analytics via the dashboard for viruses (influenza, RSV, norovirus, Hep C) and chemical metabolites, enabling government officials to access actionable insights to prioritize interventions and tackle public health proactively.

Contact Information

Website
www.biobot.io
Formerly Known As
Biobot Lab
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 501 Massachusetts Avenue
  • Cambridge, MA 02139
  • United States
+1 (424)
Primary Industry
Business/Productivity Software
Other Industries
Media and Information Services (B2B)
Database Software
Environmental Services (B2B)
Corporate Office
  • 501 Massachusetts Avenue
  • Cambridge, MA 02139
  • United States
+1 (424)

Biobot Analytics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biobot Analytics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Secondary Transaction - Private 01-Feb-2026 Completed Generating Revenue
12. Later Stage VC (Series A1) 06-Jun-2025 Completed Generating Revenue
11. Later Stage VC 17-Jul-2023 Completed Generating Revenue
10. Early Stage VC (Series A) 22-Oct-2021 Completed Generating Revenue
9. Accelerator/Incubator 01-May-2020 Completed Generating Revenue
8. Seed Round 17-Apr-2020 Completed Generating Revenue
7. Grant 15-Apr-2020 Completed Product In Beta Test
6. Accelerator/Incubator 20-Mar-2018 Completed Startup
5. Accelerator/Incubator 12-Sep-2017 $20K $40K Completed Startup
4. Accelerator/Incubator 18-May-2017 $20K $20K Completed Startup
To view Biobot Analytics’s complete valuation and funding history, request access »

Biobot Analytics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed-2
Seed-1 11,421,407 $0.001000 $0.56 $0.56 1x $0.56 32.92%
To view Biobot Analytics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Biobot Analytics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a wastewater analysis tool designed to deliver untapped insights into human health and behavior. The compan
Business/Productivity Software
Cambridge, MA
26 As of 2026

Yehud, Israel
 

Chilworth, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biobot Analytics Competitors (2)

One of Biobot Analytics’s 2 competitors is TaKaDu, a Venture Capital-Backed company based in Yehud, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
TaKaDu Venture Capital-Backed Yehud, Israel
Inflowmatix Formerly VC-backed Chilworth, United Kingdom
You’re viewing 2 of 2 competitors. Get the full list »

Biobot Analytics Patents

Biobot Analytics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200385296-A1 Method for characterizing the prevalence of a biochemical condition within a population Inactive 04-Jun-2019
US-11714030-B2 Modular system for upstream wastewater sampling Active 31-Jul-2018
US-20200072709-A1 Modular system for upstream wastewater sampling Active 31-Jul-2018
US-20230324260-A1 Modular system for upstream wastewater sampling Pending 31-Jul-2018 G01N1/20

Biobot Analytics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biobot Analytics Investors (33)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atreides Management Hedge Fund Minority
Brightwing Capital Venture Capital Minority
JSL Health Capital Growth/Expansion Minority
FDVC Management Venture Capital Minority
Republic Capital Adviser Venture Capital Minority
You’re viewing 5 of 33 investors. Get the full list »

Biobot Analytics FAQs

  • When was Biobot Analytics founded?

    Biobot Analytics was founded in 2017.

  • Where is Biobot Analytics headquartered?

    Biobot Analytics is headquartered in Cambridge, MA.

  • What is the size of Biobot Analytics?

    Biobot Analytics has 26 total employees.

  • What industry is Biobot Analytics in?

    Biobot Analytics’s primary industry is Business/Productivity Software.

  • Is Biobot Analytics a private or public company?

    Biobot Analytics is a Private company.

  • What is Biobot Analytics’s current revenue?

    The current revenue for Biobot Analytics is .

  • How much funding has Biobot Analytics raised over time?

    Biobot Analytics has raised $41.2M.

  • Who are Biobot Analytics’s investors?

    Atreides Management, Brightwing Capital, JSL Health Capital, FDVC Management, and Republic Capital Adviser are 5 of 33 investors who have invested in Biobot Analytics.

  • Who are Biobot Analytics’s competitors?

    TaKaDu and Inflowmatix are competitors of Biobot Analytics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process